First Generic of Cyclosporine Ophthalmic Emulsion Eye Drops (Restasis) Approved for Dry Eye

The FDA approved the first generic version of cyclosporine ophthalmic emulsion 0.05% single-use vials (Restasis) to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. The new generic cyclosporine ophthalmic emulsion 0.05% is the first generic of the drug approved since the approval of Restasis in the United States nearly 20 years ago. 

The approved generic of cyclosporine ophthalmic emulsion 0.05% is a product of Mylan Pharmaceuticals.